Cranberries and lower urinary tract infection prevention

Area of Science:

• Urology
• Infectious Diseases
• Natural Product Research

Background:

• Lower urinary tract infections (LUTIs) are prevalent, with recurrent cases posing treatment challenges.
• Long-term antibiotic prophylaxis is the primary treatment but risks bacterial resistance.
• Alternative preventive strategies are needed to mitigate antibiotic resistance concerns.

Purpose of the Study:

• To review the scientific evidence on using cranberry products for preventing recurrent lower urinary tract infections (LUTIs).
• To evaluate in vitro studies and clinical trials assessing cranberry's efficacy and mechanisms.

Main Methods:

• Systematic review of in vitro studies investigating cranberry's antimicrobial properties.
• Analysis of clinical trials evaluating cranberry products (juices, supplements) for LUTI prevention.
• Examination of proposed mechanisms of action, such as inhibition of bacterial adhesion.

Main Results:

• In vitro data suggest cranberry compounds can inhibit uropathogen adhesion to bladder epithelial cells.
• Clinical evidence indicates cranberry may reduce the incidence of recurrent LUTIs in certain populations.
• Effectiveness can vary based on cranberry product type, dosage, and patient demographics.

Conclusions:

• Cranberry products represent a viable non-antibiotic option for preventing recurrent lower urinary tract infections.
• Further research is warranted to optimize cranberry formulations and identify patient subgroups most likely to benefit.
• Integrating cranberry into preventive strategies may help reduce antibiotic reliance and combat resistance.